# Comparison of Hyaluronic Acid, Injectable Platelet-Rich Fibrin, and Prolotherapy in TMJ Arthrocentesis

> **NCT07479693** · NA · COMPLETED · sponsor: **Ondokuz Mayıs University** · enrollment: 36 (actual)

## Conditions studied

- Temporomandibular Joint Pain
- Arthrocentesis

## Interventions

- **PROCEDURE:** Temporomandibular Joint Arthrocentesis
- **DRUG:** Hyaluronic Acid (Orthovisc)
- **BIOLOGICAL:** Injectable Platelet-Rich Fibrin (i-PRF)
- **DRUG:** Dextrose prolotherapy (DPT)

## Key facts

- **NCT ID:** NCT07479693
- **Lead sponsor:** Ondokuz Mayıs University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-01
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07479693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07479693, "Comparison of Hyaluronic Acid, Injectable Platelet-Rich Fibrin, and Prolotherapy in TMJ Arthrocentesis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07479693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*